nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentostatin—Nucleic Acid Synthesis Inhibitors—Cytarabine—lymphatic system cancer	0.639	1	CiPCiCtD
Pentostatin—Cladribine—Fludarabine—lymphatic system cancer	0.0398	0.129	CrCrCtD
Pentostatin—Vidarabine—Fludarabine—lymphatic system cancer	0.0398	0.129	CrCrCtD
Pentostatin—Adenosine—Fludarabine—lymphatic system cancer	0.0398	0.129	CrCrCtD
Pentostatin—Azacitidine—Fludarabine—lymphatic system cancer	0.0398	0.129	CrCrCtD
Pentostatin—Vidarabine—Cytarabine—lymphatic system cancer	0.0376	0.122	CrCrCtD
Pentostatin—Adenosine—Cytarabine—lymphatic system cancer	0.0376	0.122	CrCrCtD
Pentostatin—Azacitidine—Cytarabine—lymphatic system cancer	0.0376	0.122	CrCrCtD
Pentostatin—Decitabine—Cytarabine—lymphatic system cancer	0.0358	0.116	CrCrCtD
Pentostatin—Hallucination—Carmustine—lymphatic system cancer	9.87e-05	0.00188	CcSEcCtD
Pentostatin—Sweating—Mitoxantrone—lymphatic system cancer	9.85e-05	0.00187	CcSEcCtD
Pentostatin—Dyspnoea—Fludarabine—lymphatic system cancer	9.82e-05	0.00187	CcSEcCtD
Pentostatin—Oedema peripheral—Carmustine—lymphatic system cancer	9.77e-05	0.00186	CcSEcCtD
Pentostatin—Dyspepsia—Fludarabine—lymphatic system cancer	9.69e-05	0.00185	CcSEcCtD
Pentostatin—Dysarthria—Methotrexate—lymphatic system cancer	9.67e-05	0.00184	CcSEcCtD
Pentostatin—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	9.67e-05	0.00184	CcSEcCtD
Pentostatin—Sinusitis—Mitoxantrone—lymphatic system cancer	9.64e-05	0.00183	CcSEcCtD
Pentostatin—Agranulocytosis—Mitoxantrone—lymphatic system cancer	9.59e-05	0.00182	CcSEcCtD
Pentostatin—Decreased appetite—Fludarabine—lymphatic system cancer	9.57e-05	0.00182	CcSEcCtD
Pentostatin—Visual impairment—Carmustine—lymphatic system cancer	9.56e-05	0.00182	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	9.51e-05	0.00181	CcSEcCtD
Pentostatin—Fatigue—Fludarabine—lymphatic system cancer	9.49e-05	0.00181	CcSEcCtD
Pentostatin—Hallucination—Vincristine—lymphatic system cancer	9.42e-05	0.00179	CcSEcCtD
Pentostatin—Pain—Fludarabine—lymphatic system cancer	9.42e-05	0.00179	CcSEcCtD
Pentostatin—Constipation—Fludarabine—lymphatic system cancer	9.42e-05	0.00179	CcSEcCtD
Pentostatin—Bradycardia—Mitoxantrone—lymphatic system cancer	9.39e-05	0.00179	CcSEcCtD
Pentostatin—Vasculitis—Methotrexate—lymphatic system cancer	9.37e-05	0.00178	CcSEcCtD
Pentostatin—Haemoglobin—Mitoxantrone—lymphatic system cancer	9.27e-05	0.00176	CcSEcCtD
Pentostatin—Rhinitis—Mitoxantrone—lymphatic system cancer	9.24e-05	0.00176	CcSEcCtD
Pentostatin—Hypersensitivity—Teniposide—lymphatic system cancer	9.23e-05	0.00176	CcSEcCtD
Pentostatin—Haemorrhage—Mitoxantrone—lymphatic system cancer	9.22e-05	0.00176	CcSEcCtD
Pentostatin—Pharyngitis—Mitoxantrone—lymphatic system cancer	9.15e-05	0.00174	CcSEcCtD
Pentostatin—Pulmonary embolism—Methotrexate—lymphatic system cancer	9.15e-05	0.00174	CcSEcCtD
Pentostatin—Anaemia—Bleomycin—lymphatic system cancer	9.14e-05	0.00174	CcSEcCtD
Pentostatin—Feeling abnormal—Fludarabine—lymphatic system cancer	9.07e-05	0.00173	CcSEcCtD
Pentostatin—Asthenia—Teniposide—lymphatic system cancer	8.99e-05	0.00171	CcSEcCtD
Pentostatin—Pruritus—Teniposide—lymphatic system cancer	8.86e-05	0.00169	CcSEcCtD
Pentostatin—Arrhythmia—Carmustine—lymphatic system cancer	8.86e-05	0.00169	CcSEcCtD
Pentostatin—Leukopenia—Bleomycin—lymphatic system cancer	8.85e-05	0.00169	CcSEcCtD
Pentostatin—Alopecia—Carmustine—lymphatic system cancer	8.77e-05	0.00167	CcSEcCtD
Pentostatin—Body temperature increased—Fludarabine—lymphatic system cancer	8.7e-05	0.00166	CcSEcCtD
Pentostatin—Cough—Bleomycin—lymphatic system cancer	8.63e-05	0.00164	CcSEcCtD
Pentostatin—Aplastic anaemia—Methotrexate—lymphatic system cancer	8.59e-05	0.00164	CcSEcCtD
Pentostatin—Diarrhoea—Teniposide—lymphatic system cancer	8.57e-05	0.00163	CcSEcCtD
Pentostatin—Myalgia—Bleomycin—lymphatic system cancer	8.42e-05	0.0016	CcSEcCtD
Pentostatin—Chest pain—Bleomycin—lymphatic system cancer	8.42e-05	0.0016	CcSEcCtD
Pentostatin—Alopecia—Vincristine—lymphatic system cancer	8.37e-05	0.00159	CcSEcCtD
Pentostatin—Chills—Mitoxantrone—lymphatic system cancer	8.27e-05	0.00158	CcSEcCtD
Pentostatin—Neoplasm—Methotrexate—lymphatic system cancer	8.27e-05	0.00157	CcSEcCtD
Pentostatin—Arrhythmia—Mitoxantrone—lymphatic system cancer	8.24e-05	0.00157	CcSEcCtD
Pentostatin—Alopecia—Mitoxantrone—lymphatic system cancer	8.15e-05	0.00155	CcSEcCtD
Pentostatin—Confusional state—Bleomycin—lymphatic system cancer	8.14e-05	0.00155	CcSEcCtD
Pentostatin—Hypersensitivity—Fludarabine—lymphatic system cancer	8.11e-05	0.00154	CcSEcCtD
Pentostatin—Infection—Bleomycin—lymphatic system cancer	8.02e-05	0.00153	CcSEcCtD
Pentostatin—Anaemia—Carmustine—lymphatic system cancer	7.98e-05	0.00152	CcSEcCtD
Pentostatin—Vomiting—Teniposide—lymphatic system cancer	7.97e-05	0.00152	CcSEcCtD
Pentostatin—Sepsis—Methotrexate—lymphatic system cancer	7.94e-05	0.00151	CcSEcCtD
Pentostatin—Agitation—Carmustine—lymphatic system cancer	7.94e-05	0.00151	CcSEcCtD
Pentostatin—Thrombocytopenia—Bleomycin—lymphatic system cancer	7.9e-05	0.0015	CcSEcCtD
Pentostatin—Asthenia—Fludarabine—lymphatic system cancer	7.9e-05	0.0015	CcSEcCtD
Pentostatin—Rash—Teniposide—lymphatic system cancer	7.9e-05	0.0015	CcSEcCtD
Pentostatin—Dermatitis—Teniposide—lymphatic system cancer	7.89e-05	0.0015	CcSEcCtD
Pentostatin—Headache—Teniposide—lymphatic system cancer	7.85e-05	0.00149	CcSEcCtD
Pentostatin—Pruritus—Fludarabine—lymphatic system cancer	7.79e-05	0.00148	CcSEcCtD
Pentostatin—Leukopenia—Carmustine—lymphatic system cancer	7.73e-05	0.00147	CcSEcCtD
Pentostatin—Anorexia—Bleomycin—lymphatic system cancer	7.7e-05	0.00146	CcSEcCtD
Pentostatin—Thrombophlebitis—Methotrexate—lymphatic system cancer	7.67e-05	0.00146	CcSEcCtD
Pentostatin—Anaemia—Vincristine—lymphatic system cancer	7.62e-05	0.00145	CcSEcCtD
Pentostatin—Agitation—Vincristine—lymphatic system cancer	7.57e-05	0.00144	CcSEcCtD
Pentostatin—Hypotension—Bleomycin—lymphatic system cancer	7.54e-05	0.00144	CcSEcCtD
Pentostatin—Diarrhoea—Fludarabine—lymphatic system cancer	7.53e-05	0.00143	CcSEcCtD
Pentostatin—Convulsion—Carmustine—lymphatic system cancer	7.48e-05	0.00142	CcSEcCtD
Pentostatin—Hypertension—Carmustine—lymphatic system cancer	7.45e-05	0.00142	CcSEcCtD
Pentostatin—Nausea—Teniposide—lymphatic system cancer	7.44e-05	0.00142	CcSEcCtD
Pentostatin—Anaemia—Mitoxantrone—lymphatic system cancer	7.42e-05	0.00141	CcSEcCtD
Pentostatin—Vertigo—Vincristine—lymphatic system cancer	7.41e-05	0.00141	CcSEcCtD
Pentostatin—Leukopenia—Vincristine—lymphatic system cancer	7.38e-05	0.0014	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	7.36e-05	0.0014	CcSEcCtD
Pentostatin—Myalgia—Carmustine—lymphatic system cancer	7.35e-05	0.0014	CcSEcCtD
Pentostatin—Chest pain—Carmustine—lymphatic system cancer	7.35e-05	0.0014	CcSEcCtD
Pentostatin—Anxiety—Carmustine—lymphatic system cancer	7.33e-05	0.00139	CcSEcCtD
Pentostatin—Paraesthesia—Bleomycin—lymphatic system cancer	7.25e-05	0.00138	CcSEcCtD
Pentostatin—Dyspnoea—Bleomycin—lymphatic system cancer	7.2e-05	0.00137	CcSEcCtD
Pentostatin—Leukopenia—Mitoxantrone—lymphatic system cancer	7.19e-05	0.00137	CcSEcCtD
Pentostatin—Convulsion—Vincristine—lymphatic system cancer	7.14e-05	0.00136	CcSEcCtD
Pentostatin—Hypertension—Vincristine—lymphatic system cancer	7.12e-05	0.00135	CcSEcCtD
Pentostatin—Confusional state—Carmustine—lymphatic system cancer	7.11e-05	0.00135	CcSEcCtD
Pentostatin—Decreased appetite—Bleomycin—lymphatic system cancer	7.02e-05	0.00134	CcSEcCtD
Pentostatin—Myalgia—Vincristine—lymphatic system cancer	7.02e-05	0.00134	CcSEcCtD
Pentostatin—Cough—Mitoxantrone—lymphatic system cancer	7e-05	0.00133	CcSEcCtD
Pentostatin—Infection—Carmustine—lymphatic system cancer	7e-05	0.00133	CcSEcCtD
Pentostatin—Vomiting—Fludarabine—lymphatic system cancer	7e-05	0.00133	CcSEcCtD
Pentostatin—Convulsion—Mitoxantrone—lymphatic system cancer	6.96e-05	0.00132	CcSEcCtD
Pentostatin—Rash—Fludarabine—lymphatic system cancer	6.94e-05	0.00132	CcSEcCtD
Pentostatin—Dermatitis—Fludarabine—lymphatic system cancer	6.94e-05	0.00132	CcSEcCtD
Pentostatin—Hypertension—Mitoxantrone—lymphatic system cancer	6.93e-05	0.00132	CcSEcCtD
Pentostatin—Pain—Bleomycin—lymphatic system cancer	6.9e-05	0.00131	CcSEcCtD
Pentostatin—Thrombocytopenia—Carmustine—lymphatic system cancer	6.9e-05	0.00131	CcSEcCtD
Pentostatin—Headache—Fludarabine—lymphatic system cancer	6.9e-05	0.00131	CcSEcCtD
Pentostatin—Tachycardia—Carmustine—lymphatic system cancer	6.88e-05	0.00131	CcSEcCtD
Pentostatin—Chest pain—Mitoxantrone—lymphatic system cancer	6.83e-05	0.0013	CcSEcCtD
Pentostatin—Arthralgia—Mitoxantrone—lymphatic system cancer	6.83e-05	0.0013	CcSEcCtD
Pentostatin—Myalgia—Mitoxantrone—lymphatic system cancer	6.83e-05	0.0013	CcSEcCtD
Pentostatin—Anxiety—Mitoxantrone—lymphatic system cancer	6.81e-05	0.0013	CcSEcCtD
Pentostatin—Anorexia—Carmustine—lymphatic system cancer	6.72e-05	0.00128	CcSEcCtD
Pentostatin—Infection—Vincristine—lymphatic system cancer	6.68e-05	0.00127	CcSEcCtD
Pentostatin—Feeling abnormal—Bleomycin—lymphatic system cancer	6.65e-05	0.00127	CcSEcCtD
Pentostatin—Osteoarthritis—Methotrexate—lymphatic system cancer	6.64e-05	0.00126	CcSEcCtD
Pentostatin—Confusional state—Mitoxantrone—lymphatic system cancer	6.61e-05	0.00126	CcSEcCtD
Pentostatin—Nervous system disorder—Vincristine—lymphatic system cancer	6.6e-05	0.00126	CcSEcCtD
Pentostatin—Thrombocytopenia—Vincristine—lymphatic system cancer	6.59e-05	0.00125	CcSEcCtD
Pentostatin—Hypotension—Carmustine—lymphatic system cancer	6.59e-05	0.00125	CcSEcCtD
Pentostatin—Nausea—Fludarabine—lymphatic system cancer	6.54e-05	0.00124	CcSEcCtD
Pentostatin—Infection—Mitoxantrone—lymphatic system cancer	6.51e-05	0.00124	CcSEcCtD
Pentostatin—Hyperhidrosis—Vincristine—lymphatic system cancer	6.5e-05	0.00124	CcSEcCtD
Pentostatin—Shock—Mitoxantrone—lymphatic system cancer	6.45e-05	0.00123	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	6.42e-05	0.00122	CcSEcCtD
Pentostatin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	6.41e-05	0.00122	CcSEcCtD
Pentostatin—Urticaria—Bleomycin—lymphatic system cancer	6.41e-05	0.00122	CcSEcCtD
Pentostatin—Anorexia—Vincristine—lymphatic system cancer	6.41e-05	0.00122	CcSEcCtD
Pentostatin—Tachycardia—Mitoxantrone—lymphatic system cancer	6.39e-05	0.00122	CcSEcCtD
Pentostatin—Body temperature increased—Bleomycin—lymphatic system cancer	6.38e-05	0.00121	CcSEcCtD
Pentostatin—Insomnia—Carmustine—lymphatic system cancer	6.37e-05	0.00121	CcSEcCtD
Pentostatin—Skin disorder—Mitoxantrone—lymphatic system cancer	6.36e-05	0.00121	CcSEcCtD
Pentostatin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	6.33e-05	0.00121	CcSEcCtD
Pentostatin—Paraesthesia—Carmustine—lymphatic system cancer	6.33e-05	0.0012	CcSEcCtD
Pentostatin—Mood swings—Methotrexate—lymphatic system cancer	6.29e-05	0.0012	CcSEcCtD
Pentostatin—Hypotension—Vincristine—lymphatic system cancer	6.29e-05	0.0012	CcSEcCtD
Pentostatin—Dyspnoea—Carmustine—lymphatic system cancer	6.28e-05	0.0012	CcSEcCtD
Pentostatin—Somnolence—Carmustine—lymphatic system cancer	6.26e-05	0.00119	CcSEcCtD
Pentostatin—Anorexia—Mitoxantrone—lymphatic system cancer	6.24e-05	0.00119	CcSEcCtD
Pentostatin—Ataxia—Methotrexate—lymphatic system cancer	6.24e-05	0.00119	CcSEcCtD
Pentostatin—Liver function test abnormal—Methotrexate—lymphatic system cancer	6.13e-05	0.00117	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	6.13e-05	0.00117	CcSEcCtD
Pentostatin—Decreased appetite—Carmustine—lymphatic system cancer	6.13e-05	0.00117	CcSEcCtD
Pentostatin—Hypotension—Mitoxantrone—lymphatic system cancer	6.12e-05	0.00117	CcSEcCtD
Pentostatin—Insomnia—Vincristine—lymphatic system cancer	6.08e-05	0.00116	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	6.08e-05	0.00116	CcSEcCtD
Pentostatin—Paraesthesia—Vincristine—lymphatic system cancer	6.04e-05	0.00115	CcSEcCtD
Pentostatin—Constipation—Carmustine—lymphatic system cancer	6.03e-05	0.00115	CcSEcCtD
Pentostatin—Pain—Carmustine—lymphatic system cancer	6.03e-05	0.00115	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	5.97e-05	0.00114	CcSEcCtD
Pentostatin—Hypersensitivity—Bleomycin—lymphatic system cancer	5.95e-05	0.00113	CcSEcCtD
Pentostatin—Paraesthesia—Mitoxantrone—lymphatic system cancer	5.88e-05	0.00112	CcSEcCtD
Pentostatin—Decreased appetite—Vincristine—lymphatic system cancer	5.85e-05	0.00111	CcSEcCtD
Pentostatin—Dyspnoea—Mitoxantrone—lymphatic system cancer	5.84e-05	0.00111	CcSEcCtD
Pentostatin—Somnolence—Mitoxantrone—lymphatic system cancer	5.82e-05	0.00111	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	5.81e-05	0.00111	CcSEcCtD
Pentostatin—Feeling abnormal—Carmustine—lymphatic system cancer	5.81e-05	0.00111	CcSEcCtD
Pentostatin—Fatigue—Vincristine—lymphatic system cancer	5.8e-05	0.0011	CcSEcCtD
Pentostatin—Asthenia—Bleomycin—lymphatic system cancer	5.79e-05	0.0011	CcSEcCtD
Pentostatin—Dyspepsia—Mitoxantrone—lymphatic system cancer	5.77e-05	0.0011	CcSEcCtD
Pentostatin—Gastrointestinal pain—Carmustine—lymphatic system cancer	5.76e-05	0.0011	CcSEcCtD
Pentostatin—Pain—Vincristine—lymphatic system cancer	5.75e-05	0.0011	CcSEcCtD
Pentostatin—Constipation—Vincristine—lymphatic system cancer	5.75e-05	0.0011	CcSEcCtD
Pentostatin—Asthma—Methotrexate—lymphatic system cancer	5.74e-05	0.00109	CcSEcCtD
Pentostatin—Pruritus—Bleomycin—lymphatic system cancer	5.71e-05	0.00109	CcSEcCtD
Pentostatin—Decreased appetite—Mitoxantrone—lymphatic system cancer	5.7e-05	0.00108	CcSEcCtD
Pentostatin—Fatigue—Mitoxantrone—lymphatic system cancer	5.65e-05	0.00108	CcSEcCtD
Pentostatin—Constipation—Mitoxantrone—lymphatic system cancer	5.6e-05	0.00107	CcSEcCtD
Pentostatin—Pain—Mitoxantrone—lymphatic system cancer	5.6e-05	0.00107	CcSEcCtD
Pentostatin—Abdominal pain—Carmustine—lymphatic system cancer	5.57e-05	0.00106	CcSEcCtD
Pentostatin—Body temperature increased—Carmustine—lymphatic system cancer	5.57e-05	0.00106	CcSEcCtD
Pentostatin—Gastrointestinal pain—Vincristine—lymphatic system cancer	5.5e-05	0.00105	CcSEcCtD
Pentostatin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	5.4e-05	0.00103	CcSEcCtD
Pentostatin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	5.36e-05	0.00102	CcSEcCtD
Pentostatin—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	5.33e-05	0.00102	CcSEcCtD
Pentostatin—Abdominal pain—Vincristine—lymphatic system cancer	5.32e-05	0.00101	CcSEcCtD
Pentostatin—Body temperature increased—Vincristine—lymphatic system cancer	5.32e-05	0.00101	CcSEcCtD
Pentostatin—Erectile dysfunction—Methotrexate—lymphatic system cancer	5.29e-05	0.00101	CcSEcCtD
Pentostatin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	5.24e-05	0.000997	CcSEcCtD
Pentostatin—Urticaria—Mitoxantrone—lymphatic system cancer	5.2e-05	0.000991	CcSEcCtD
Pentostatin—Hypersensitivity—Carmustine—lymphatic system cancer	5.19e-05	0.000988	CcSEcCtD
Pentostatin—Abdominal pain—Mitoxantrone—lymphatic system cancer	5.18e-05	0.000986	CcSEcCtD
Pentostatin—Body temperature increased—Mitoxantrone—lymphatic system cancer	5.18e-05	0.000986	CcSEcCtD
Pentostatin—Pneumonia—Methotrexate—lymphatic system cancer	5.15e-05	0.00098	CcSEcCtD
Pentostatin—Vomiting—Bleomycin—lymphatic system cancer	5.13e-05	0.000977	CcSEcCtD
Pentostatin—Depression—Methotrexate—lymphatic system cancer	5.1e-05	0.000971	CcSEcCtD
Pentostatin—Rash—Bleomycin—lymphatic system cancer	5.09e-05	0.000969	CcSEcCtD
Pentostatin—Dermatitis—Bleomycin—lymphatic system cancer	5.09e-05	0.000968	CcSEcCtD
Pentostatin—Asthenia—Carmustine—lymphatic system cancer	5.06e-05	0.000962	CcSEcCtD
Pentostatin—Renal failure—Methotrexate—lymphatic system cancer	5.03e-05	0.000958	CcSEcCtD
Pentostatin—Stomatitis—Methotrexate—lymphatic system cancer	4.99e-05	0.00095	CcSEcCtD
Pentostatin—Conjunctivitis—Methotrexate—lymphatic system cancer	4.97e-05	0.000947	CcSEcCtD
Pentostatin—Hypersensitivity—Vincristine—lymphatic system cancer	4.96e-05	0.000943	CcSEcCtD
Pentostatin—Sweating—Methotrexate—lymphatic system cancer	4.91e-05	0.000934	CcSEcCtD
Pentostatin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	4.83e-05	0.000919	CcSEcCtD
Pentostatin—Asthenia—Vincristine—lymphatic system cancer	4.83e-05	0.000919	CcSEcCtD
Pentostatin—Diarrhoea—Carmustine—lymphatic system cancer	4.82e-05	0.000918	CcSEcCtD
Pentostatin—Nausea—Bleomycin—lymphatic system cancer	4.8e-05	0.000913	CcSEcCtD
Pentostatin—Agranulocytosis—Methotrexate—lymphatic system cancer	4.78e-05	0.000909	CcSEcCtD
Pentostatin—Asthenia—Mitoxantrone—lymphatic system cancer	4.7e-05	0.000895	CcSEcCtD
Pentostatin—Dizziness—Carmustine—lymphatic system cancer	4.66e-05	0.000887	CcSEcCtD
Pentostatin—Haemoglobin—Methotrexate—lymphatic system cancer	4.62e-05	0.000879	CcSEcCtD
Pentostatin—Diarrhoea—Vincristine—lymphatic system cancer	4.6e-05	0.000876	CcSEcCtD
Pentostatin—Haemorrhage—Methotrexate—lymphatic system cancer	4.59e-05	0.000875	CcSEcCtD
Pentostatin—Pharyngitis—Methotrexate—lymphatic system cancer	4.56e-05	0.000868	CcSEcCtD
Pentostatin—Diarrhoea—Mitoxantrone—lymphatic system cancer	4.48e-05	0.000853	CcSEcCtD
Pentostatin—Vomiting—Carmustine—lymphatic system cancer	4.48e-05	0.000853	CcSEcCtD
Pentostatin—Dizziness—Vincristine—lymphatic system cancer	4.45e-05	0.000847	CcSEcCtD
Pentostatin—Rash—Carmustine—lymphatic system cancer	4.44e-05	0.000846	CcSEcCtD
Pentostatin—Dermatitis—Carmustine—lymphatic system cancer	4.44e-05	0.000845	CcSEcCtD
Pentostatin—Visual impairment—Methotrexate—lymphatic system cancer	4.43e-05	0.000843	CcSEcCtD
Pentostatin—Headache—Carmustine—lymphatic system cancer	4.41e-05	0.00084	CcSEcCtD
Pentostatin—Tinnitus—Methotrexate—lymphatic system cancer	4.28e-05	0.000815	CcSEcCtD
Pentostatin—Vomiting—Vincristine—lymphatic system cancer	4.28e-05	0.000814	CcSEcCtD
Pentostatin—Rash—Vincristine—lymphatic system cancer	4.24e-05	0.000807	CcSEcCtD
Pentostatin—Dermatitis—Vincristine—lymphatic system cancer	4.24e-05	0.000807	CcSEcCtD
Pentostatin—Headache—Vincristine—lymphatic system cancer	4.21e-05	0.000802	CcSEcCtD
Pentostatin—Nausea—Carmustine—lymphatic system cancer	4.19e-05	0.000797	CcSEcCtD
Pentostatin—Vomiting—Mitoxantrone—lymphatic system cancer	4.17e-05	0.000793	CcSEcCtD
Pentostatin—Rash—Mitoxantrone—lymphatic system cancer	4.13e-05	0.000786	CcSEcCtD
Pentostatin—Dermatitis—Mitoxantrone—lymphatic system cancer	4.13e-05	0.000786	CcSEcCtD
Pentostatin—Chills—Methotrexate—lymphatic system cancer	4.12e-05	0.000785	CcSEcCtD
Pentostatin—Headache—Mitoxantrone—lymphatic system cancer	4.1e-05	0.000781	CcSEcCtD
Pentostatin—Alopecia—Methotrexate—lymphatic system cancer	4.06e-05	0.000773	CcSEcCtD
Pentostatin—Nausea—Vincristine—lymphatic system cancer	4e-05	0.000761	CcSEcCtD
Pentostatin—Nausea—Mitoxantrone—lymphatic system cancer	3.89e-05	0.000741	CcSEcCtD
Pentostatin—Anaemia—Methotrexate—lymphatic system cancer	3.7e-05	0.000704	CcSEcCtD
Pentostatin—Vertigo—Methotrexate—lymphatic system cancer	3.59e-05	0.000684	CcSEcCtD
Pentostatin—Leukopenia—Methotrexate—lymphatic system cancer	3.58e-05	0.000681	CcSEcCtD
Pentostatin—Cough—Methotrexate—lymphatic system cancer	3.49e-05	0.000664	CcSEcCtD
Pentostatin—Convulsion—Methotrexate—lymphatic system cancer	3.47e-05	0.00066	CcSEcCtD
Pentostatin—Chest pain—Methotrexate—lymphatic system cancer	3.41e-05	0.000648	CcSEcCtD
Pentostatin—Arthralgia—Methotrexate—lymphatic system cancer	3.41e-05	0.000648	CcSEcCtD
Pentostatin—Myalgia—Methotrexate—lymphatic system cancer	3.41e-05	0.000648	CcSEcCtD
Pentostatin—Confusional state—Methotrexate—lymphatic system cancer	3.29e-05	0.000627	CcSEcCtD
Pentostatin—Infection—Methotrexate—lymphatic system cancer	3.24e-05	0.000617	CcSEcCtD
Pentostatin—Nervous system disorder—Methotrexate—lymphatic system cancer	3.2e-05	0.000609	CcSEcCtD
Pentostatin—Thrombocytopenia—Methotrexate—lymphatic system cancer	3.2e-05	0.000608	CcSEcCtD
Pentostatin—Skin disorder—Methotrexate—lymphatic system cancer	3.17e-05	0.000604	CcSEcCtD
Pentostatin—Hyperhidrosis—Methotrexate—lymphatic system cancer	3.16e-05	0.000601	CcSEcCtD
Pentostatin—Anorexia—Methotrexate—lymphatic system cancer	3.11e-05	0.000592	CcSEcCtD
Pentostatin—Hypotension—Methotrexate—lymphatic system cancer	3.05e-05	0.000581	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	2.97e-05	0.000566	CcSEcCtD
Pentostatin—Insomnia—Methotrexate—lymphatic system cancer	2.95e-05	0.000562	CcSEcCtD
Pentostatin—Paraesthesia—Methotrexate—lymphatic system cancer	2.93e-05	0.000558	CcSEcCtD
Pentostatin—Dyspnoea—Methotrexate—lymphatic system cancer	2.91e-05	0.000554	CcSEcCtD
Pentostatin—Somnolence—Methotrexate—lymphatic system cancer	2.9e-05	0.000552	CcSEcCtD
Pentostatin—Dyspepsia—Methotrexate—lymphatic system cancer	2.87e-05	0.000547	CcSEcCtD
Pentostatin—Decreased appetite—Methotrexate—lymphatic system cancer	2.84e-05	0.00054	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	2.82e-05	0.000536	CcSEcCtD
Pentostatin—Fatigue—Methotrexate—lymphatic system cancer	2.81e-05	0.000536	CcSEcCtD
Pentostatin—Pain—Methotrexate—lymphatic system cancer	2.79e-05	0.000531	CcSEcCtD
Pentostatin—Feeling abnormal—Methotrexate—lymphatic system cancer	2.69e-05	0.000512	CcSEcCtD
Pentostatin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	2.67e-05	0.000508	CcSEcCtD
Pentostatin—Urticaria—Methotrexate—lymphatic system cancer	2.59e-05	0.000494	CcSEcCtD
Pentostatin—Abdominal pain—Methotrexate—lymphatic system cancer	2.58e-05	0.000491	CcSEcCtD
Pentostatin—Body temperature increased—Methotrexate—lymphatic system cancer	2.58e-05	0.000491	CcSEcCtD
Pentostatin—Hypersensitivity—Methotrexate—lymphatic system cancer	2.4e-05	0.000458	CcSEcCtD
Pentostatin—Asthenia—Methotrexate—lymphatic system cancer	2.34e-05	0.000446	CcSEcCtD
Pentostatin—Pruritus—Methotrexate—lymphatic system cancer	2.31e-05	0.00044	CcSEcCtD
Pentostatin—Diarrhoea—Methotrexate—lymphatic system cancer	2.23e-05	0.000425	CcSEcCtD
Pentostatin—Dizziness—Methotrexate—lymphatic system cancer	2.16e-05	0.000411	CcSEcCtD
Pentostatin—Vomiting—Methotrexate—lymphatic system cancer	2.08e-05	0.000395	CcSEcCtD
Pentostatin—Rash—Methotrexate—lymphatic system cancer	2.06e-05	0.000392	CcSEcCtD
Pentostatin—Dermatitis—Methotrexate—lymphatic system cancer	2.06e-05	0.000391	CcSEcCtD
Pentostatin—Headache—Methotrexate—lymphatic system cancer	2.04e-05	0.000389	CcSEcCtD
Pentostatin—Nausea—Methotrexate—lymphatic system cancer	1.94e-05	0.000369	CcSEcCtD
